219 related articles for article (PubMed ID: 31072138)
1. Identification of novel blood-based HCC-specific diagnostic biomarkers for human hepatocellular carcinoma.
Yin L; He N; Chen C; Zhang N; Lin Y; Xia Q
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1908-1916. PubMed ID: 31072138
[TBL] [Abstract][Full Text] [Related]
2. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential biomarkers of peripheral blood mononuclear cell in hepatocellular carcinoma using bioinformatic analysis: A protocol for systematic review and meta-analysis.
Peng JL; Wu JZ; Li GJ; Wu JL; Xi YM; Li XQ; Wang L
Medicine (Baltimore); 2021 Jan; 100(2):e24172. PubMed ID: 33466191
[TBL] [Abstract][Full Text] [Related]
4. Identification of Key Biological Processes, Pathways, Networks, and Genes with Potential Prognostic Values in Hepatocellular Carcinoma Using a Bioinformatics Approach.
Lu H; Zhu Q
Cancer Biother Radiopharm; 2021 Dec; 36(10):837-849. PubMed ID: 32598174
[No Abstract] [Full Text] [Related]
5. A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma.
Shi M; Chen MS; Sekar K; Tan CK; Ooi LL; Hui KM
Eur J Cancer; 2014 Mar; 50(5):928-36. PubMed ID: 24332572
[TBL] [Abstract][Full Text] [Related]
6. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
7. Insights into significant pathways and gene interaction networks in peripheral blood mononuclear cells for early diagnosis of hepatocellular carcinoma.
Jiang JX; Yu C; Li ZP; Xiao J; Zhang H; Chen MY; Sun CY
J Cancer Res Ther; 2016; 12(2):981-9. PubMed ID: 27461685
[TBL] [Abstract][Full Text] [Related]
8. Identification of Potential Gene Network Associated with HCV-Related Hepatocellular Carcinoma Using Microarray Analysis.
Cheng Y; Ping J; Chen J
Pathol Oncol Res; 2018 Jul; 24(3):507-514. PubMed ID: 28669080
[TBL] [Abstract][Full Text] [Related]
9. Identification of Circulating Biomarker Candidates for Hepatocellular Carcinoma (HCC): An Integrated Prioritization Approach.
Awan FM; Naz A; Obaid A; Ali A; Ahmad J; Anjum S; Janjua HA
PLoS One; 2015; 10(9):e0138913. PubMed ID: 26414287
[TBL] [Abstract][Full Text] [Related]
10. RNA-seq profiling reveals PBMC RNA as a potential biomarker for hepatocellular carcinoma.
Han Z; Feng W; Hu R; Ge Q; Ma W; Zhang W; Xu S; Zhan B; Zhang L; Sun X; Zhou X
Sci Rep; 2021 Sep; 11(1):17797. PubMed ID: 34493740
[TBL] [Abstract][Full Text] [Related]
11. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
[TBL] [Abstract][Full Text] [Related]
12. Utility of miR‑133a‑3p as a diagnostic indicator for hepatocellular carcinoma: An investigation combined with GEO, TCGA, meta‑analysis and bioinformatics.
Liang HW; Yang X; Wen DY; Gao L; Zhang XY; Ye ZH; Luo J; Li ZY; He Y; Pang YY; Chen G
Mol Med Rep; 2018 Jan; 17(1):1469-1484. PubMed ID: 29138825
[TBL] [Abstract][Full Text] [Related]
13. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.
Li L; Lei Q; Zhang S; Kong L; Qin B
Oncol Rep; 2017 Nov; 38(5):2607-2618. PubMed ID: 28901457
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatic analysis reveals CYP2C9 as a potential prognostic marker for HCC and liver cancer cell lines suitable for its mechanism study.
Shuaichen L; Guangyi W
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(7):70-74. PubMed ID: 29974848
[TBL] [Abstract][Full Text] [Related]
15. The predictive powers of plasma trefoil factor 3 or its related micro RNAs for patients with hepatocellular carcinoma.
Zhang C; Xia R; Zhang B; Wang H
BMC Cancer; 2018 Nov; 18(1):1110. PubMed ID: 30424721
[TBL] [Abstract][Full Text] [Related]
16. Identification of BHLHE40 expression in peripheral blood mononuclear cells as a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma.
Kunadirek P; Ariyachet C; Sriphoosanaphan S; Pinjaroen N; Sirichindakul P; Nookaew I; Chuaypen N; Tangkijvanich P
Sci Rep; 2021 May; 11(1):11201. PubMed ID: 34045534
[TBL] [Abstract][Full Text] [Related]
17. Multi-parameter gene expression profiling of peripheral blood for early detection of hepatocellular carcinoma.
Xie H; Xue YQ; Liu P; Zhang PJ; Tian ST; Yang Z; Guo Z; Wang HM
World J Gastroenterol; 2018 Jan; 24(3):371-378. PubMed ID: 29391759
[TBL] [Abstract][Full Text] [Related]
18. RASSF1A and SOCS1 genes methylation status as a noninvasive marker for hepatocellular carcinoma.
Pasha HF; Mohamed RH; Radwan MI
Cancer Biomark; 2019; 24(2):241-247. PubMed ID: 30689554
[TBL] [Abstract][Full Text] [Related]
19. Critical genes of hepatocellular carcinoma revealed by network and module analysis of RNA-seq data.
Yang MR; Zhang Y; Wu XX; Chen W
Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4248-4256. PubMed ID: 27831650
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic significance and potential function of miR-338-5p in hepatocellular carcinoma: A bioinformatics study with microarray and RNA sequencing data.
Liang L; Gao L; Zou XP; Huang ML; Chen G; Li JJ; Cai XY
Mol Med Rep; 2018 Feb; 17(2):2297-2312. PubMed ID: 29207053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]